Plain-English translation of NCT07166081 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
This is an early-stage study testing a new medication called in people who are overweight or obese but do not have diabetes. Researchers want to understand how the medication works in the body, whether it helps with weight management, and whether it is safe to use. You would receive either the medication or a placebo (a dummy pill) in increasing doses over the course of the study.
Many people struggle to manage their weight despite diet and exercise, and current treatment options are limited. This medication targets a natural hormone system in the body that controls hunger and blood sugar, and researchers believe it may help people lose weight or prevent weight gain.
You would visit the research center regularly to receive either the medication or a placebo by mouth, starting at a low dose and gradually increasing it. At each visit, researchers would check your health, draw blood to measure how your body responds to the medication, and monitor for any side effects. The study involves multiple cohorts (groups), so depending on which group you join, you might receive one of several different doses.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
United States